drugset / Trial / NCT05991466

Effect of Dexmedetomidine on the Quality of Recovery in Parturients Undergoing Elective Caesarean Sections

NCT05991466 ↗

Phase 4 Completed 141 enrolled Cairo University
RandomizedParallel-groupTriple-blindSupportive care

Summary

The study hypothesizes that addition of dexmedetomidine to bupivacaine either in spinal anesthesia or TAP block is more effective and provide better ObsQor-11score than bupivacaine alone. Also, Dexmedetomidine in TAP block might provide a longer pain free time in comparison to intrathecal dexmedetomidine.

Timeline

Start
2022-01-01
Primary completion
2022-09-30
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 5 ug Intrathecal
Comparator Dexmedetomidine Other / unclassified 50 ug Intrathecal

Indications

No indication recorded.